Insider Sell: Chief Scientific Officer Edward Feener Sells 17,321 Shares of KalVista ...

Edward Feener, Chief Scientific Officer of KalVista Pharmaceuticals Inc (NASDAQ:KALV), executed a sale of 17,321 shares in the company on January 9, 2024, according to a recent SEC Filing.

Related Keywords

,Kalvista Pharmaceuticals Inc ,Urufocus ,Pharmaceutical Company ,Edward Feener ,Chief Scientific Officer ,Fec Filing ,